Beyond Air To Participate in the Truist Securities BioPharma Symposium

17.10.2023 - GARDEN CITY, N.Y., Oct. 17, 2023 (GLOBE NEWSWIRE) - Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”) a commercial stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric ... Seite 1

Related Keywords

New York ,United States ,Steve Lisi ,Nasdaq ,Cancer Ltd ,Company Presentation ,Beyond Cancer ,Chief Executive Officer ,Beyond Air ,Truist Securities Biopharma Symposium ,Truist Securities ,Beyond Air Chart ,Eyond Air Kurs ,Eyond Air Aktie ,